Please login to the form below

Not currently logged in
Email:
Password:

Nelsons appoints new leadership team to US office

Pat Schneider, John Ende and Brad Baker join the firm

Natural healthcare company Nelsons has appointed a new leadership team to direct its US office.

The UK's largest manufacturer of natural healthcare products has named Pat Schneider as CEO for Nelsons Back USA. Schneider has worked at numerous consumer health and wellness firms within the industry including Johnson & Johnson, Bristol-Myers Squibb and Procter & Gamble.

Most recently, she held the role of chief operating officer at Twinlab, a nutritional products company, where she was responsible for manufacturing, distribution, logistics and leading the new product development process.

John Ende has been named as VP of sales for North America. Most recently, he served as executive VP of sales at Hello Products, aiding to grow the firm's breath spray to become the top selling spray in the USA.

Additionally, Brad Baker has been named as Nelsons VP of marketing, also starting his career in sales and marketing at Johnson & Johnson. Baker has spent over 20 years working in various global marketing roles including stints at Gilette and Procter & Gamble. He also aided building brands such as Oral-B.

Schneider commented: “I am thrilled to have John and Brad on board at Nelson Bach USA.  My leadership team and I are more than ready to embrace our challenges and we have got the best tools with which to do it – strong management, new product launches this year, great experience in the health and personal care markets and a determined drive to build on our mass channels. There are exciting times ahead for RESCUE and PurAbsorb.”

16th March 2015

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics